kr22.88
1.42% today
Stockholm, Oct 21, 11:09 am CET
ISIN
SE0013647385
Symbol
BICO

Bico Group Stock price

kr22.56
+1.00 4.64% 1M
-13.30 37.09% 6M
-9.46 29.54% YTD
-17.58 43.80% 1Y
-11.87 34.48% 3Y
-181.94 88.97% 5Y
-33.44 59.71% 10Y
-33.44 59.71% 20Y
Stockholm, Closing price Mon, Oct 20 2025
-0.90 3.84%

Key metrics

Basic
Market capitalization
kr1.7b
Enterprise Value
kr2.4b
Net debt
kr723.8m
Cash
kr684.3m
Shares outstanding
70.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.9 | 1.1
EV/Sales
1.3 | 1.5
EV/FCF
13.5
P/B
0.6
Financial Health
Equity Ratio
54.4%
Return on Equity
-0.2%
ROCE
-5.6%
ROIC
-4.9%
Debt/Equity
0.5
Financials (TTM | estimate)
Revenue
kr1.8b | kr1.6b
EBITDA
- | kr67.9m
EBIT
kr-174.1m | kr-196.6m
Net Income
kr-211.3m | kr-404.8m
Free Cash Flow
kr176.1m
Growth (TTM | estimate)
Revenue
-19.2% | -19.9%
EBITDA
- | -23.2%
EBIT
5.6% | 30.4%
Net Income
88.8% | -7,259.6%
Free Cash Flow
279.9%
Margin (TTM | estimate)
Gross
54.1%
EBITDA
- | 4.4%
EBIT
-9.5%
Net
-11.6% | -26.0%
Free Cash Flow
9.7%
More
EPS
kr-3.0
FCF per Share
kr2.5
Short interest
-
Employees
710
Rev per Employee
kr2.7m
Show more

Is Bico Group a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Bico Group Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Bico Group forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a Bico Group forecast:

Buy
75%
Hold
25%

Financial data from Bico Group

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,825 1,825
19% 19%
100%
- Direct Costs 838 838
25% 25%
46%
987 987
13% 13%
54%
- Selling and Administrative Expenses 804 804
17% 17%
44%
- Research and Development Expense 160 160
248% 248%
9%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -174 -174
6% 6%
-10%
Net Profit -211 -211
89% 89%
-12%

In millions SEK.

Don't miss a Thing! We will send you all news about Bico Group directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Cellink AB engages in the development and commercialization of bioprinting technologies. It prints 3D human organs and tissues for the development of pharmaceutical and cosmetic products. Its products include Inkredible, Bio X, Bio X6, Holograph X, Lumen X, and bioinks. The company was founded by Erik Gatenholm and Hector Daniel Martinez Avila in 2016 and is headquartered in Gothenburg, Sweden.

Head office Sweden
CEO Maria Forss
Employees 710
Founded 2016
Website bico.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today